MarketSmith India is a stock research platform that provides investors and traders with analysis tools, including stock screeners, watchlists, and chart patterns. MarketSmith India utilizes the CAN SLIM methodology developed by William J. O'Neil to identify promising investment opportunities.

Here are some of MarketSmith India's stock recommendations for today, August 8, 2025:

Godrej Consumer Products:

• CMP (Current Market Price): ₹1,160
• Buy At: ₹1,160
• Target Price: ₹1,350 in 3 months
• Stop Loss: ₹1,080
• Key Metrics: P/E: 61.24, 52-week high: ₹1,542, volume: ₹51.14 cr

Hindustan Unilever:

• CMP (Current Market Price): ₹2,249
• Buy At: ₹2,249
• Target Price: ₹2,500 in 3 months
• Stop Loss: ₹2,150
• Key Metrics: P/E: 50.85, 52-week high: ₹3,035, volume: ₹34.35 cr

Choice International Ltd:

• Buy At: ₹ 518.7
• Target Price: ₹610 in 3 months
• Stop Loss: ₹480
• Key Metrics: P/E: 68.83, 52-week high: ₹ 568.90, volume: ₹4.37 Lakh

Bharat Dynamics Ltd:

• Buy At: ₹1,343.50
• Target Price: ₹1,700 in 3 months
• Stop Loss: ₹1,190
• Key Metrics: P/E: 83.83, 52-week high: ₹1,794, volume: ₹ 556.75 Cr

Market Trends and Outlook:

On Thursday, Nifty50 closed flat due to investor concerns about fresh geopolitical tensions after the US President's announcement of an additional 25% tariff on Indian exports. The index experienced volatility, fluctuating between 24,350 and 24,650, but recovered in the latter half of the session to close near 24,600.

The market status was downgraded to "Uptrend Under Pressure" on July 18th, with seven distribution days.

Other stocks to watch:

• Torrent Pharma is looking strong, gaining around 6% from the pivot level in 11 days.
• Vishnu Chemical is on the verge of a breakout, 2% away from the pivot level, with strong volume accumulation.
• Sumito Chemical has already broken out.
• Bosch is a leading technology and service provider in mobility solutions, industrial technology, consumer goods, and energy building technology.

Disclaimer: This article is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a financial advisor.